Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Treatment Approach
2.3.2 Market Size By Disorder Type
2.3.3 Market Size By Care Setting
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Active Pharmaceutical Ingredient (API) & Excipient Suppliers
3.4.2 Drug Manufacturers & Digital Therapeutics Developers
3.4.3 Hospitals, Specialty Pharmacies & Treatment Service Providers
3.4.4 Patients, Rehabilitation Centers & Community Care Organizations
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Epidemiology & Disease Burden Analysis
4.1.1 Overview
4.1.2 Prevalence & Incidence Analysis By Disorder Type, 2022–2035
4.1.3 Patient Population Analysis By Key Countries
4.2 Treatment Adoption & Utilization Trends
4.2.1 Overview
4.2.2 Treatment Adoption Trends By Care Setting
4.2.3 Treatment Utilization Trends By End User
4.3 Healthcare Infrastructure & Access Analysis
4.3.1 Overview
4.3.2 Treatment Facility Distribution By Region, 2022–2035
4.3.3 Healthcare Professional Availability Analysis
4.3.4 Reimbursement & Coverage Trends
4.3.5 Digital Treatment Accessibility Trends
5. Substance Use Disorder Treatment Market Segmental Analysis & Forecast, By Treatment Approach, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Medication-Assisted Treatment
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Behavioral Therapy & Counseling
5.4 Residential & Inpatient Rehabilitation
5.5 Digital Telehealth & Remote Treatment
5.6 Others
6. Substance Use Disorder Treatment Market Segmental Analysis & Forecast, By Disorder Type, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Alcohol Use Disorder
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Opioid Use Disorder
6.4 Stimulant Use Disorder
6.5 Cannabis Use Disorder
6.6 Other Substance Use Disorders
7. Substance Use Disorder Treatment Market Segmental Analysis & Forecast, By Care Setting, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Outpatient Treatment Centers
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Residential Treatment Centers
7.4 Hospitals & Inpatient Facilities
7.5 Home-Based & Virtual Care
7.6 Community & Correctional Programs
8. Substance Use Disorder Treatment Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Specialty Addiction Treatment Providers
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Hospitals & Health Systems
8.4 Government & Community Health Programs
8.5 Physician Practices & Mental Health Clinics
8.6 Employers, Payers & Digital Health Platforms
8.7 Others
9. Substance Use Disorder Treatment Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Substance Use Disorder Treatment Market Size & Forecast, By Treatment Approach, 2022–2035
9.2.3 Substance Use Disorder Treatment Market Size & Forecast, By Disorder Type, 2022–2035
9.2.4 Substance Use Disorder Treatment Market Size & Forecast, By Care Setting, 2022–2035
9.2.5 Substance Use Disorder Treatment Market Size & Forecast, By End User, 2022–2035
9.2.6 Substance Use Disorder Treatment Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Substance Use Disorder Treatment Market Size & Forecast, By Treatment Approach, 2022–2035
9.3.3 Substance Use Disorder Treatment Market Size & Forecast, By Disorder Type, 2022–2035
9.3.4 Substance Use Disorder Treatment Market Size & Forecast, By Care Setting, 2022–2035
9.3.5 Substance Use Disorder Treatment Market Size & Forecast, By End User, 2022–2035
9.3.6 Substance Use Disorder Treatment Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Substance Use Disorder Treatment Market Size & Forecast, By Treatment Approach, 2022–2035
9.4.3 Substance Use Disorder Treatment Market Size & Forecast, By Disorder Type, 2022–2035
9.4.4 Substance Use Disorder Treatment Market Size & Forecast, By Care Setting, 2022–2035
9.4.5 Substance Use Disorder Treatment Market Size & Forecast, By End User, 2022–2035
9.4.6 Substance Use Disorder Treatment Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Substance Use Disorder Treatment Market Size & Forecast, By Treatment Approach, 2022–2035
9.5.3 Substance Use Disorder Treatment Market Size & Forecast, By Disorder Type, 2022–2035
9.5.4 Substance Use Disorder Treatment Market Size & Forecast, By Care Setting, 2022–2035
9.5.5 Substance Use Disorder Treatment Market Size & Forecast, By End User, 2022–2035
9.5.6 Substance Use Disorder Treatment Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Substance Use Disorder Treatment Market Size & Forecast, By Treatment Approach, 2022–2035
9.6.3 Substance Use Disorder Treatment Market Size & Forecast, By Disorder Type, 2022–2035
9.6.4 Substance Use Disorder Treatment Market Size & Forecast, By Care Setting, 2022–2035
9.6.5 Substance Use Disorder Treatment Market Size & Forecast, By End User, 2022–2035
9.6.6 Substance Use Disorder Treatment Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022–2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Treatment Approach/Service & Disorder Type Benchmarking
10.4.1 Treatment Approach/Service Specifications & Features By Key Players
10.4.2 Treatment Approach/Service Heatmap By Key Players
10.4.3 Disorder Type Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Indivior PLC
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Treatment Approach/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Alkermes plc
10.6.3 Camurus AB
10.6.4 Orexo AB
10.6.5 Braeburn Inc.
10.6.6 Titan Pharmaceuticals, Inc.
10.6.7 BioCorRx Inc.
10.6.8 Adial Pharmaceuticals, Inc.
10.6.9 Emergent BioSolutions Inc.
10.6.10 Dr. Reddy's Laboratories Ltd.
10.6.11 Viatris Inc.
10.6.12 Mallinckrodt Pharmaceuticals
10.6.13 BayMark Health Services
10.6.14 Acadia Healthcare
10.6.15 Universal Health Services
10.6.16 Hazelden Betty Ford Foundation
10.6.17 American Addiction Centers
10.6.18 Pyramid Healthcare
10.6.19 Teva Pharmaceutical Industries Ltd.
10.6.20 Hikma Pharmaceuticals PLC
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
The market is projected to reach USD 23.46 Billion by 2035.
The market is anticipated to expand at a CAGR of 7.02% during the forecast period.
North America dominated the global Substance Use Disorder Treatment Market in 2025.
Medication-Assisted Treatment accounted for the largest revenue share of 42.00% in 2025.